Organogenesis Holdings (ORGO) Interest Expenses (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Interest Expenses of -$380000.0 for Q1 2026, down 103.01% year-over-year from $12.6 million in Q1 2025, and down 103.08% quarter-over-quarter from $12.3 million in Q4 2025.
Organogenesis Holdings (ORGO) Interest Expenses (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Interest Expenses history runs 11 years deep, the most recent figure standing at -$380000.0 for Q1 2026.
- In Q1 2026, Interest Expenses fell 103.01% year-over-year to -$380000.0; the TTM figure through Mar 2026 stood at $20.4 million (up 61.12% YoY), while the FY2025 annual figure was $20.0 million, up 33.49% from the prior year.
- Interest Expenses for Q1 2026 stood at -$380000.0, down from $12.3 million in the prior quarter.
- The five-year high for Interest Expenses was $66.1 million in Q2 2022, with the low at -$5.0 million in Q4 2022.
- The 5-year median for Interest Expenses is $9.3 million (2023), against an average of $19.5 million.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses tumbled 452.42% in 2022, then soared 370.81% in 2024.
- Organogenesis Holdings' Interest Expenses stood at -$5.0 million in 2022, then soared by 157.26% to $2.8 million in 2023, then jumped by 370.81% to $13.4 million in 2024, then slipped by 7.67% to $12.3 million in 2025, then plunged by 103.08% to -$380000.0 in 2026.
- Business Quant data shows ORGO's Interest Expenses at -$380000.0 in Q1 2026, $12.3 million in Q4 2025, and $10.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Organogenesis Holdings | 244.48 Mn | 197.64 Mn | 20.08 Mn | -138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -138,000.00 |
| Jun 30, 2026 | -138,000.00 |
| Mar 31, 2026 | -380,000.00 |
| Mar 31, 2026 | -380,000.00 |
| Dec 31, 2025 | 12.33 Mn |
| Dec 31, 2025 | 12.33 Mn |
| Sep 30, 2025 | 10.76 Mn |
| Sep 30, 2025 | 10.76 Mn |
| Jun 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | 5.52 Mn |
| Mar 31, 2025 | 12.63 Mn |
| Mar 31, 2025 | 12.63 Mn |
| Dec 31, 2024 | 13.36 Mn |
| Dec 31, 2024 | 13.36 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 7.48 Mn |
| Mar 31, 2024 | 7.48 Mn |